<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>pharmaceutical expenditure &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/pharmaceutical-expenditure/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Wed, 14 Oct 2026 18:28:13 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.3</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>pharmaceutical expenditure &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Medicines Without Competition Now Eat Up Nearly 40% of Italy&#8217;s Public Drug Budget</title>
		<link>https://bioengineer.org/medicines-without-competition-now-eat-up-nearly-40-of-italys-public-drug-budget/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Wed, 14 Oct 2026 18:28:13 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[drug pricing]]></category>
		<category><![CDATA[drug regulation]]></category>
		<category><![CDATA[health economics]]></category>
		<category><![CDATA[health technology assessment]]></category>
		<category><![CDATA[Italian National Health Service]]></category>
		<category><![CDATA[Italy]]></category>
		<category><![CDATA[non-competition medicines]]></category>
		<category><![CDATA[pharmaceutical expenditure]]></category>
		<category><![CDATA[pharmacoeconomics]]></category>
		<category><![CDATA[public finance]]></category>
		<category><![CDATA[spending projections]]></category>
		<category><![CDATA[value-based pricing]]></category>
		<guid isPermaLink="false">https://bioengineer.org/?p=419313</guid>

					<description><![CDATA[A new Italian Medicines Agency analysis shows that medicines without market competition consumed 9.6 billion euros, or 38.6 percent, of Italy's public pharmaceutical spending in 2023, with sales more than doubling within three years of launch.]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">419313</post-id>	</item>
	</channel>
</rss>
